Rapid TEG results on arrival
| TEG parameter | All patients (n=678) | Pregnant (n=76) | Non-pregnant (n=301) | Male (n=301) | P value* |
| ACT (s) | 113 (105–121) | 113 (105–121) | 105 (105–113) | 113 (105–121) | <0.001 |
| Split point time (min) | 0.5 (0.4–0.6) | 0.5 (0.4–0.6) | 0.5 (0.4–0.6) | 0.6 (0.5–0.6) | 0.003 |
| Reaction time (min) | 0.7 (0.6–0.8) | 0.7 (0.6–0.8) | 0.6 (0.5–0.7) | 0.7 (0.6–0.8) | <0.001 |
| Kinetic time (min) | 1.2 (1.0–1.7) | 1.1 (0.9–1.2) | 1.2 (0.9–1.4) | 1.5 (1.2–1.8) | <0.001 |
| α angle (°) | 75 (71–77) | 77 (74–79) | 76 (73–78) | 72 (68–75) | <0.001 |
| Maximum amplitude (mm) | 65 (60–69) | 69 (65–72) | 67 (62–70) | 63 (57–66) | <0.001 |
| G-value (d/sc) | 9.1 (7.4–11.1) | 11 (9.3–13) | 9.9 (8.0–11.7) | 8.1 (6.7–9.5) | 0.001 |
| LY-30 (%) | 1.5 (0.4–3.2) | 0.8 (0–2.7) | 1.7 (0.5–3.4) | 1.5 (0.4–3.2) | 0.02 |
| Coagulation index | 3.7 (3.0–4.4) | 4.4 (3.8–4.8) | 4.1 (3.3–4.6) | 3.4 (2.7–3.9) | <0.001 |
| TEG category | |||||
| Hypocoagulable (MA ≤55) | 61 (9%) | 5 (7%) | 21 (7%) | 35 (12%) | 0.10 |
| Hypocoagulable (α angle ≤60°) | 24 (4%) | 3 (4%) | 6 (2%) | 15 (5%) | 0.14 |
| High LY-30 (lysis ≥3.0%) | 213 (31%) | 17 (22%) | 103 (34%) | 93 (31%) | 0.10 |
| Normocoagulable (MA 56–64) | 275 (41%) | 11 (14%) | 102 (34%) | 162 (54%) | <0.001 |
| Normocoagulable (α angle 61°–75°) | 379 (56%) | 24 (32%) | 137 (46%) | 218 (72%) | <0.001 |
| Physiologic lysis | 222 (33%) | 19 (25%) | 101 (34%) | 102 (34%) | 0.20 |
| Hypercoagulable (α angle ≥76°) | 275 (41%) | 49 (64%) | 158 (52%) | 68 (23%) | <0.001 |
| Hypercoagulable (MA ≥65) | 342 (50%) | 60 (79%) | 178 (59%) | 104 (34%) | <0.001 |
| Low LY-30 (lysis ≤0.8%) | 243 (36%) | 40 (53%) | 97 (32%) | 106 (35%) | 0.005 |
Continuous data presented as median (IQR).
*Results of Kruskal-Wallis test.
ACT, activated clotting time; LY-30, lysis 30 min after MA; MA, maximum amplitude; TEG, thrombelastography.